-transparent.png){kind=logo}
The authors tested the effectiveness of orally administered delta-9-tetrahydrocannabinol (THC) as compared to prochlorperazine for the alleviation of symptoms, such as vomiting and nausea, experienced by patients receiving radiotherapy. The test subjects rated the severity of their illness, as well as the extent of their subsequent moods, their level of concentration, their amount of physical activity, and their desire for social interaction. They chose the drug they preferred and recorded its side effects. The use of THC was slightly more beneficial than the use of prochlorperazine.
Related Publications
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
June 1974,
Anesthesiology,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
January 1980,
The New England journal of medicine,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
October 1997,
Anesthesia and analgesia,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
October 2012,
Anesthesia and analgesia,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
January 1997,
Paediatric anaesthesia,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
January 2023,
Journal of cancer research and therapeutics,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
October 1991,
British journal of clinical pharmacology,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
December 1982,
Cancer chemotherapy and pharmacology,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
January 1984,
Clinical pharmacy,
J T Ungerleider, and
T A Andrysiak, and
L A Fairbanks, and
A S Tesler, and
R G Parker
November 1958,
The American journal of psychiatry,
